Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19. Hammond J, Leister-Tebbe H, Gardner A, Abreu P, et al. N Engl J Med 2022 Feb 16. doi: 10.1056/NEJMoa2118542.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hammond J, Leister-Tebbe H, Gardner A, Abreu P, et al. Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19. N Engl J Med 2022 Feb 16. doi: 10.1056/NEJMoa2118542.
PMID: 35172054